Kevin Chan, OD, MS, discusses an AAOpt 2026 symposium on individualized low-dose atropine dosing for myopia and the FDA outlook ahead of the SYD-101 advisory meeting.
|Videos|September 5, 2019
How to start incorporating dry eye in your practice
Author(s)Scott Schachter, OD
Advertisement
The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or MJH Life Sciences.
Related:
Advertisement
Related to this article
Raman Bhakhri, OD, FAAO, alongside Xiao Yu, OD, FAAO, discussed emerging investigational therapies for the disease during their AAOpt 2026 session.
Jamie Kuzniar, OD, FAAO, FSLS, discusses a case-based AAOpt 2026 session on scleral lens complications, fitting around cross-linking, and advice for new graduates.
Kwaku Osei, OD, PhD, FAAO, discussed patient-reported outcomes with a senofilcon C (Johnson & Johnson; Acuvue Vita), reusable lens, with the majority of wearers rating comfort, vision, and handling favorably.
Andrew Pucker, OD, PhD, FAAO, FSLS, FBCLA, discussed how oculomics research presented at AAOpt 2026 could eventually support point-of-care diagnosis and referral decisions.
Lloyd Williams, MD, PhD, discusses rising cataract blindness and low-cost surgery in conflict zones for World Sight Day.
A handful of eye care providers spoke on the factors that have led to a lack of eye care access for World Sight Day.
Kevin Chan, OD, MS, FAAO, FBCLA, IACMM, stated in his Rapid Fire lecture that high myopes shouldn't be counted out of orthokeratology treatment.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2026: Understanding the gene therapy landscape for retinitis pigmentosa
2
Epioxa epi-on cross-linking holds keratoconus gains at 3 years
3
AAOpt 2026: Evaluating the comfort and usability of Acuvue Vita contact lenses
4
Independent OD practices net 31% of revenue, IDOC benchmarks show
5